Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Filings indexed 2,588 across all filing types
Latest filing 2023-10-27 Regulatory Filings
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Please find the enclosed investor presentation for Q2FY24 unaudited financial result.
Regulatory Filings
2023-10-27 English
Press Release
Regulatory Filings
2023-10-27 English
Please find the attached enclosed the press release dated 27th October 2023.
Regulatory Filings
2023-10-27 English
Copy of Newspaper Publication
Regulatory Filings
2023-10-27 English
Please find the attached extract of the consolidated unaudited financial results for the quarter ended 30th September 2023 to be published in newspaper.
Regulatory Filings
2023-10-27 English
Please find the attached Unaudited financial results.
Regulatory Filings
2023-10-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.